Structure-activity relationships of novel hematoregulatory peptides

被引:36
|
作者
Bhatnagar, PK
Agner, EK
Alberts, D
Arbo, BE
Callahan, JF
Cuthbertson, AS
Engelsen, SJ
Fjerdingstad, H
Hartmann, M
Heerding, D
Hiebl, J
Huffman, WF
Hysben, M
King, AG
Kremminger, P
Kwon, C
LoCastro, S
Lovhaug, D
Pelus, LM
Petteway, S
Takata, JS
机构
[1] SMITHKLINE BEECHAM PHARMACEUT, DEPT MOL VIROL & HOST DEF, KING OF PRUSSIA, PA 19406 USA
[2] NYCOMED PHARMA AS, OSLO, NORWAY
[3] HAFSLUND NYCOMBED PHARMA AG, A-4021 LINZ, AUSTRIA
关键词
D O I
10.1021/jm960099d
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Hematopoiesis is a lifelong cell renewal process regulated by a family of lineage specific hematopoietic growth factors. Several hematopoietic growth factors such as G-CSF, GM-CSF, and M-CSF have been clinically evaluated for enhancement of host defense in normal and immunocompromised patients and for the treatment of infectious diseases, This paper reports the structure-activity relationships of low molecular weight hematoregulatory peptides based ori a nonapeptide (1, SK&F 107647). Like the macromolecular growth. factors, these peptides modulate host defense. A molecular target for this class of compounds has not yet been identified. However, the structure-activity relationships established by this study implicate a very specific molecular recognition event that is pivotal for the biological activities of 1 and its analogues.
引用
收藏
页码:3814 / 3819
页数:6
相关论文
共 50 条
  • [1] Structure-activity relationships of antiarrhythmic peptides
    Dhein, S
    Grover, R
    Piecha, D
    Tudyka, T
    Kruesemann, K
    Klaus, W
    [J]. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1998, 357 (04) : R101 - R101
  • [2] Structure-activity relationships of antibacterial peptides
    Ciulla, Maria Gessica
    Gelain, Fabrizio
    [J]. MICROBIAL BIOTECHNOLOGY, 2023, 16 (04): : 757 - 777
  • [3] Review:: Structure-activity relationships in β-defensin peptides
    Taylor, Karen
    Barran, Perdita E.
    Dorin, Julia R.
    [J]. BIOPOLYMERS, 2008, 90 (01) : 1 - 7
  • [4] Structure-Activity Relationships of Multifunctional Host Defence Peptides
    Kindrachuk, J.
    Napper, S.
    [J]. MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2010, 10 (07) : 596 - 614
  • [5] Structure-Activity Relationships of Hydroxyapatite-Binding Peptides
    Ling, Chen
    Zhao, Weilong
    Wang, Ziqiu
    Chen, Jiadong
    Ustriyana, Putu
    Gao, Min
    Sahai, Nita
    [J]. LANGMUIR, 2020, 36 (10) : 2729 - 2739
  • [6] Structure-activity relationships for synthetic peptides and peptidomimetics of thrombin
    Clement, CC
    Philipp, M
    [J]. BIOCHEMISTRY, 2003, 42 (28) : 8631 - 8631
  • [7] Structure-activity relationships of gliadin peptides in coeliac disease
    Kocna, P.
    Vanickova, Z.
    Hlavata, J.
    Topinkova, K.
    [J]. FEBS JOURNAL, 2009, 276 : 318 - 319
  • [8] Structure-activity relationships in cyclic β-sheet antibacterial peptides
    Kondejewski, LH
    Jelokhani-Niaraki, M
    Hancock, REW
    Hodges, RS
    [J]. PEPTIDES: FRONTIERS OF PEPTIDES SCIENCE, 1999, : 152 - 153
  • [9] STRUCTURE-ACTIVITY RELATIONSHIPS IN PEPTIDES: PAST AND PRESENT CONCEPTS
    Pliska, V.
    [J]. JOURNAL OF PEPTIDE SCIENCE, 2004, 10 : 107 - 107
  • [10] Enamines as novel antibacterials and their structure-activity relationships
    Xiao, Zhu-Ping
    Fang, Rui-Qin
    Li, Huan-Qiu
    Xue, Jia-Yu
    Zheng, Yi
    Zhu, Hai-Liang
    [J]. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2008, 43 (09) : 1828 - 1836